Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment - Wikidata - awgldk - TriplyDB

Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment

Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment

http://www.wikidata.org/entity/Q34740258

about

Adult vaccination Staphylococcus aureus biofilms: properties, regulation, and roles in human disease Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine The role of microbial biofilms in prosthetic joint infections Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue.Biofilm Disrupting Technology for Orthopedic Implants: What's on the Horizon?Biofilms in periprosthetic orthopedic infections In vivo expression of Streptococcus pyogenes immunogenic proteins during tibial foreign body infection Detection of Alpha-Toxin and Other Virulence Factors in Biofilms of Staphylococcus aureus on Polystyrene and a Human Epidermal Model Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Vaccines for Acinetobacter baumannii: thinking "out of the box".Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.[Management of biofilm-associated infections: what can we expect from recent research on biofilm lifestyles?].Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters.Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood.Ventricular shunt infections: immunopathogenesis and clinical management.Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.Mycobacterium tuberculosis pellicles express unique proteins recognized by the host humoral response.Immunoproteomic Identification of In Vivo-Produced Propionibacterium acnes Proteins in a Rabbit Biofilm Infection Model Modelling the interaction between the host immune response, bacterial dynamics and inflammatory damage in comparison with immunomodulation and vaccination experiments Deciphering mechanisms of staphylococcal biofilm evasion of host immunity.Urinary catheter indwelling clinical pathogen biofilm formation, exopolysaccharide characterization and their growth influencing parameters.Draft Genome Sequence of the Methicillin-Resistant Staphylococcus aureus Isolate MRSA-M2 Anti-glucosaminidase IgG in sera as a biomarker of host immunity against Staphylococcus aureus in orthopaedic surgery patients Staphylococcus aureus-dependent septic arthritis in murine knee joints: local immune response and beneficial effects of vaccination.Prevention and treatment of Staphylococcus aureus biofilms.Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.Hiding in Plain Sight: Interplay between Staphylococcal Biofilms and Host Immunity Comparison of 3 real-time, quantitative murine models of staphylococcal biofilm infection by using in vivo bioluminescent imaging Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection.New approaches for treating staphylococcal biofilm infections.Interaction of Staphylococcus aureus with osteoblasts (Review).Antibiofilm agents and implant-related infections in orthopaedics: where are we?Anti-biofilm agents: recent breakthrough against multi-drug resistant Staphylococcus aureus.Protein-based biofilm matrices in Staphylococci.Development of broad-spectrum antibiofilm drugs: strategies and challenges.Quorum quenching: role in nature and applied developments.Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent.Combining in vitro protein detection and in vivo antibody detection identifies potential vaccine targets against Staphylococcus aureus during osteomyelitis.

P2860

Q26824961-16213748-473F-4B1A-A104-FF8FACAEAC6A Q27006715-BA8DA102-5DB3-4D97-86C1-25BDBBE97F47 Q27008338-7806D18C-6D04-4D87-88B0-2DE2AF366DE1 Q27021270-3196AFC5-B47D-4675-9F56-1F2C2AAFF3E1 Q27323146-3E5152EE-EC73-44BC-B817-69E739B4E759 Q28083459-9B12441A-3B1C-4E64-B3CE-51094CFD3AB8 Q28392406-99ABE9B0-011D-450A-8A0B-46FBF4DCC34D Q28395445-E16AC9D5-C9B3-4BF1-B2F7-BF8C554E3EA9 Q28552176-35B38E34-4B25-415A-BD9F-24816D288DF9 Q30403958-B6A027A7-B206-4B17-8DE6-A06A8346D2FC Q30424697-CC6BD163-2C71-47B4-87F1-C7BA3D9BA801 Q33637895-BA614B1A-7A86-4B35-B033-BF574D521762 Q34113328-2927B298-2659-4A14-AECB-DC8E7012BC6F Q34393088-ACBC81F0-07B8-4A44-8359-BA00CD0B1136 Q34522708-77CEA6E4-A7E2-4D53-A4AC-C6E12B1515BC Q34545013-26FEF33E-AB89-47CF-AD6B-C904915CCF7C Q34619785-D760B5C4-B42F-44B1-8C7A-9A7E79A74E9C Q34712265-19133C48-1D9F-48B3-92C9-60E2CACF8B34 Q35186462-45F1C2D2-0639-483B-84D8-1A555EE53F69 Q35548040-9B733CD2-044A-418D-AB29-3FED8F3981F2 Q35558628-40DE0C15-7D03-4D98-A1A1-A408C75D89F9 Q36158847-CFCA2805-911D-4739-8346-B1DC0884AB99 Q36442022-0B059544-4177-450C-A774-889992CF9203 Q36601196-6C0B1843-8D7F-48FB-B893-41EE5E7164BE Q37290020-8958EE08-BA27-4860-9859-DE46F447EB3C Q37454396-0AA3B4B1-C002-4BF8-BFA2-0D699435E8AB Q37482155-4DEC8756-B370-4C10-9CE8-593A4498B312 Q37548140-A8E7F251-621A-4E63-837A-C5DA8838D887 Q37555500-E35BC32C-8356-4058-BCF7-B2E0CEEF0774 Q37593295-B3332AFB-ACBE-431D-8C65-66D9DA3100C1 Q37643833-4A54078F-1E95-4267-9197-6FFF42ED4A67 Q37970722-62E6005D-308D-437F-B3C6-4C81832D925D Q38042628-E562A131-39B8-4147-8C9C-7B20232A929C Q38107655-74B0A4D6-65D3-4DC4-8872-3C99C25DFD11 Q38181039-4B11607B-09FA-4121-B1B8-2C7ACEE89C0E Q38300642-EE33C839-6B2D-4511-B2C7-D221471C32AD Q38522806-A8014991-5B73-486B-93D1-116B51A852E7 Q38598251-8E232827-A47C-4E25-BEB3-D59014974FAC Q38810296-6AC1CBBA-46C1-4172-8F64-CDF44A19C560 Q39389373-8A9C77E3-F484-487D-8516-D4735D43CE64

P2860

Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment

http://www.wikidata.org/entity/Q34740258

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Resolution of Staphylococcus a ...... ation and antibiotic treatment

@ast

Resolution of Staphylococcus a ...... ation and antibiotic treatment

@en

Resolution of Staphylococcus a ...... ation and antibiotic treatment

@nl

type

label

Resolution of Staphylococcus a ...... ation and antibiotic treatment

@ast

Resolution of Staphylococcus a ...... ation and antibiotic treatment

@en

Resolution of Staphylococcus a ...... ation and antibiotic treatment

@nl

prefLabel

Resolution of Staphylococcus a ...... ation and antibiotic treatment

@ast

Resolution of Staphylococcus a ...... ation and antibiotic treatment

@en

Resolution of Staphylococcus a ...... ation and antibiotic treatment

@nl

P1433

Q34740258-06B4E2B0-A61C-4EFD-A64A-EA4287481A25

P1476

Q34740258-6485F129-0370-442C-81E3-256ED58693C5

P2093

Q34740258-014930DE-8E35-42A3-852D-F6E36613B383

Q34740258-0971F1A8-350C-47AE-9685-D0C3DD8F26DB

Q34740258-2C87A653-6C81-4DC8-A1D1-F7B3D3EB6F0B

Q34740258-435A7749-5DDE-4E79-81EB-DD27B67D81FB

Q34740258-698B6DFD-6921-4FC8-A1E3-FC716AE9BCEC

Q34740258-7BA27966-7A06-41D5-B492-1F55835EB87A

P2860

Q34740258-16F4F652-D2A0-4558-A46B-9BB03C9C6EE0

Q34740258-1720E2A3-79BE-495C-A28A-4A474CE7E61E

Q34740258-1AD99A1C-D864-4EB5-ADFF-E78161D1E384

Q34740258-27F50891-ED9E-4663-B2B5-12C06E1878D8

Q34740258-2C7EA6B9-AC3C-4763-845B-32B89525C29E

Q34740258-31FF80E9-52BB-41A7-8323-A9183ACE06AC

Q34740258-39CC0127-700A-41C5-95B1-556444635616

Q34740258-3C3547B6-B193-4064-B1A6-59E874E5CF4C

Q34740258-433B1183-41DB-4F8B-8153-E544E3D06967

Q34740258-487EE518-7D10-4184-A273-FAD428174C35

P304

Q34740258-9D98CE15-848C-4204-AE81-340C476F00AD

P31

Q34740258-ACE63DF3-08B9-457D-A9E4-274FB047A6E9

P356

Q34740258-92D6D43C-0D68-41D9-B4A3-71974A7A4B84

P407

Q34740258-3B2286E9-1BB8-496E-BA04-AC7C83AA88A9

P433

Q34740258-5457C409-1E99-4731-BB75-CE62F2BC6F91

P478

Q34740258-D462817A-38EA-45C9-B6DC-A9CA425512FC

P577

Q34740258-6AEE1F82-7F75-46C3-9F16-D10866493694

P698

Q34740258-565EE7E6-C7F6-4A04-AD38-840B41E3A1B7

P921

Q34740258-AF24FF70-20C7-420C-8590-F7C95A380812

P932

Q34740258-C8DF8531-F2CB-43EE-B1C7-C95DE478149A

P356

P1433

Infection and Immunity

P1476

Resolution of Staphylococcus a ...... ation and antibiotic treatment

@en

P2093

Graeme A O'May

http://www.w3.org/2001/XMLSchema#string

J William Costerton

http://www.w3.org/2001/XMLSchema#string

Jeff G Leid

http://www.w3.org/2001/XMLSchema#string

Mark E Shirtliff

http://www.w3.org/2001/XMLSchema#string

Megan L Prior

http://www.w3.org/2001/XMLSchema#string

Rebecca A Brady

http://www.w3.org/2001/XMLSchema#string

P2860

Biofilms: survival mechanisms of clinically relevant microorganisms.

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA

Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection.

Physiological heterogeneity in biofilms.

Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.

Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis.

Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide.

A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model

Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.

P304

1797-1803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00451-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21220484

http://www.w3.org/2001/XMLSchema#string

P921

P932

3067561

http://www.w3.org/2001/XMLSchema#string